Guardian Capital Advisors (Canada) Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbCellera Biologics
ABCL
|
+$110M |
| 2 |
Fortis
FTS
|
+$2.87M |
| 3 |
Apple
AAPL
|
+$1.24M |
| 4 |
Cleveland-Cliffs
CLF
|
+$928K |
| 5 |
Costco
COST
|
+$676K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BCE
BCE
|
+$2.88M |
| 2 |
ORAN
Orange
ORAN
|
+$953K |
| 3 |
Unilever
UL
|
+$776K |
| 4 |
Oracle
ORCL
|
+$703K |
| 5 |
Corning
GLW
|
+$596K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 30.51% |
| 2 | Healthcare | 16.52% |
| 3 | Technology | 11.04% |
| 4 | Energy | 8.9% |
| 5 | Communication Services | 7.17% |
Similar funds
Guardian Capital Advisors (Canada)'s Q2 2021 Portfolio in Review
As of Q2 2021, Guardian Capital Advisors (Canada) held 180 positions worth $976M, up 11% from $876M the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Guardian Capital Advisors (Canada) deployed $116M of net new capital in Q2 2021, opening 9 new positions and adding to 80 existing holdings. Its largest new stake was AbCellera Biologics: 3,975,994 shares worth $81.4M.
By sector, the portfolio is most concentrated in Financials at 31% of assets, down from 36% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was BCE, an estimated $2.88M trimmed.
- Guardian Capital Advisors (Canada)'s largest Q2 2021 buy was AbCellera Biologics: 3,975,994 shares worth $81.4M.
- Guardian Capital Advisors (Canada) added most to Fortis in Q2 2021, an estimated $2.87M increase.
- Guardian Capital Advisors (Canada)'s biggest Q2 2021 reduction was BCE, cutting an estimated $2.88M.
- Guardian Capital Advisors (Canada) fully exited Regeneron Pharmaceuticals in Q2 2021, selling an estimated $529K.
- Guardian Capital Advisors (Canada)'s ten largest holdings make up 40% of its $976M portfolio in Q2 2021.
- Guardian Capital Advisors (Canada) opened 9 new positions and closed 8 in Q2 2021.
- Guardian Capital Advisors (Canada)'s portfolio value rose 11% quarter-over-quarter to $976M.
Based on Guardian Capital Advisors (Canada)'s 13F filing for Q2 2021, filed 17 Aug 2021.